The BRAF mutation accounts for around 10% cases of colon cancer and serves as a strong negative prognostic marker for patients (Davies et al., 2002; Gonsalves et al., 2014; Barras et al., 2017). The gene discussed is BRAF; the disease is malignant colon neoplasm.